Nicholas R Natale Selected Research

Ischemic Stroke

4/2021

Liposomal Encapsulated FSC231, a PICK1 Inhibitor, Prevents the Ischemia/Reperfusion-Induced Degradation of GluA2-Containing AMPA Receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas R Natale Research Topics

Disease

3	Neoplasms (Cancer) 11/2020 - 02/2009
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Stroke (Strokes) 04/2021
1	Ischemic Stroke 04/2021
1	Ischemia 04/2021
1	Brain Neoplasms (Brain Tumor) 11/2020
1	Substance-Related Disorders (Drug Abuse) 01/2012
1	Glioma (Gliomas) 08/2009
1	Alzheimer Disease (Alzheimer's Disease) 01/2006

Drug/Important Bio-Agent (IBA)

3	IsoxazolesIBA 11/2020 - 02/2009
3	AmidesIBA 11/2020 - 02/2009
2	Glutamic Acid (Glutamate)FDA Link 01/2012 - 01/2006
1	diphenyl (biphenyl)IBA 01/2022
1	FSC 231IBA 04/2021
1	CalciumIBA 04/2021
1	AMPA Receptors (AMPA Receptor)IBA 04/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2012
1	Cystine (L-Cystine)IBA 01/2012
1	Carrier Proteins (Binding Protein)IBA 01/2006
1	N-Methylaspartate (NMDA)IBA 01/2006
1	Memantine (Namenda)FDA Link 01/2006

Therapy/Procedure

1	Therapeutics 04/2021